Elastography Imaging Market to Reach US$7.5 Bn by 2032 at 7.2% CAGR | Persistence Market Research

elastography imaging market

The elastography imaging market is growing rapidly, driven by demand for non-invasive diagnostics in liver disease, breast cancer, & musculoskeletal conditions.

LONDON, UNITED KINGDOM, March 4, 2026 /EINPresswire.com/ -- The global elastography imaging market is expected to grow from USD 4.6 billion in 2025 to USD 7.5 billion by 2032, with a compound annual growth rate (CAGR) of 7.2%. Elastography, a non-invasive imaging technique, is widely used to assess tissue stiffness and diagnose conditions such as chronic liver disease, breast cancer, and musculoskeletal disorders.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/35570

Market Drivers and Challenges

Drivers of Growth

The elastography imaging market is driven by the increasing demand for non-invasive diagnostic alternatives to biopsies, particularly in the evaluation of chronic liver diseases like hepatitis B, hepatitis C, and Non-Alcoholic Fatty Liver Disease (NAFLD). Elastography helps stage liver fibrosis without requiring invasive procedures, reducing biopsy rates in countries like Germany and France. Additionally, elastography is gaining traction in breast cancer diagnosis, especially in dense breast tissue, where mammography is less effective.

Challenges to Adoption

A major challenge to elastography’s wider use is its limitations in obese patients. Excess body fat can interfere with the ultrasound signals used to generate stiffness maps, resulting in unreliable readings. A 2023 study found that liver stiffness measurements failed in 15% of obese patients. Similarly, breast elastography may not be as effective in women with dense breast tissue or large breast sizes.

Opportunities for Growth

Multi-modality elastography, which combines ultrasound elastography with other imaging techniques like Magnetic Resonance Elastography (MRE), offers improved reliability and reproducibility. This advancement is particularly useful in complex conditions such as liver diseases and oncology. The trend toward personalized medicine also presents new opportunities to track disease progression more dynamically using multi-modality data.

Market Segmentation: Modality and Application Insights

Modality

The elastography market is divided into ultrasound-based and magnetic resonance-based modalities. Ultrasound-based elastography is expected to dominate the market with a 70.1% share in 2025 due to its low cost, portability, and ease of integration into existing systems. Magnetic Resonance Elastography (MRE) is gaining popularity due to its higher reproducibility and ability to provide whole-organ coverage, particularly in liver assessments where ultrasound may face limitations.

Application

Elastography is used in various clinical applications, including general imaging, hepatology, musculoskeletal disorders, and breast cancer. The general imaging segment is expected to hold the largest market share (33.8% in 2025) as elastography can assess multiple organs, such as the liver, thyroid, and muscles, with the same system. Breast imaging is also a significant application, especially in regions where mammography is less effective in dense breast tissue, such as Europe and Asia Pacific.

Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/35570

Regional Insights

North America

North America is expected to account for 35.7% of the market share in 2025. The region benefits from favorable reimbursement policies and widespread adoption of advanced imaging technologies. In the U.S., elastography is covered under Medicare, making it a key diagnostic tool for liver disease and radiology.

Europe

In Europe, elastography adoption varies by country, with France leading the way in using transient elastography devices like FibroScan for chronic liver disease monitoring. Germany and the U.K. are increasingly integrating shear-wave elastography into multipurpose ultrasound systems, making it more cost-effective.

Asia Pacific

Asia Pacific is experiencing rapid growth in elastography adoption, particularly in China, Japan, and India. China’s rising rates of metabolic liver disease and viral hepatitis are driving the demand for elastography. Japan is investing in high-resolution elastography for advanced liver care, while India is seeing increased adoption in private hospitals.

Competitive Landscape

The elastography market is competitive, with large imaging companies such as Canon Medical Systems, FUJIFILM, Philips, and Siemens dominating the high-end segment. Smaller, specialized players are focusing on cost-effective, portable elastography solutions for specific applications like liver health.

Checkout Now & Download Complete Market Report: https://www.persistencemarketresearch.com/checkout/35570

Market Segmentation

By Modality

Ultrasound
Magnetic Resonance

By Application

General Imaging
Hepatology
Breast
Cardiology
Nephrology
Orthopedic and Musculoskeletal

By End-user

Hospitals
Imaging Centers
Others

By Region

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Recent Developments

In August 2025, Sonic Incytes Medical Corp. received FDA clearance for its Velacur ONE, a point-of-care ultrasound elastography device. In April 2025, Philips introduced an upgrade to its EPIQ Elite ultrasound system, incorporating proactive system monitoring for remote diagnosis and troubleshooting.

Conclusion

The elastography imaging market is set for robust growth due to its non-invasive nature and ability to diagnose a range of medical conditions. With advancements in multi-modality platforms and growing applications in oncology, the market is poised to expand further in the coming years.

Read Related Reports:

ASEAN Dysphagia Diet Thickening Agents Market: The ASEAN dysphagia diet thickening agents market size is projected to rise from US$26.2 Mn in 2026 to US$34.5 Mn by 2033, growing at a 7.5% CAGR.

MicroRNA Market: The microRNA market is projected to grow from US$1.7 Bn in 2026 to US$3.5 Bn by 2033, expanding at a CAGR of 10.7% over the forecast period.

Persistence Market Research
Persistence Market Research Pvt Ltd
+1 646-878-6329
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.